The effectiveness and safety of escitalopram in the treatment of major depression: A randomized double-blind active-drug controlled trial

Chinese Journal of Evidence-Based Medicine

Volumn 6, Issue 8, 2006, Pages 552-556

  Li, Jin ^a   Shen, Wen Wu ^a   Liu, Yang ^a   Xu, Li ^a   Liu, Shan Ming ^a   Kuang, Wei Hong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Citalopram; Escitalopram; Major depression; Randomized controlled trial

Indexed keywords

CITALOPRAM; ESCITALOPRAM;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; XEROSTOMIA;

EID: 33748471386     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Montgomery SA. Clinically relevant effect sizes in depresion. Eur Neuropsychopharcol. 1994; 4 (4): 283-284.
2. Hyttel J, Bogeso KP, Perregaard J, et al. The pharmacological effect of citalopram residues in the (S)-(+)-enantionmer. J Neural Transm Gen Sect, 1992;88 (2):157-159.
3. Owen MJ, Knight DL, Nemerof CB. Second generation SSRIs: human monioamine transporter blinding profile of esitapram and R-fluoxetine. Bio Psychiatry, 2001; 50 (5):345-350.
4. Von Moltke LL, Greenblatt DJ, Giancarlo GM, et al. Escitalopram(S- citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metab Dispos, 2001; 29 (9):1102-1109.
5. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients. J Clin Psychiatry, 2002; 63 (4):331-339.
6. Lepola UM, Loft H, Reines EH. Escitalopram is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol, 2003; 18 (4):211-220.